Trinity Biotech ADR buy StockNews.com
Start price
23.10.23
/
50%
€0.48
Target price
23.10.24
-
Performance (%)
-14.88%
Price
22.02.24
€0.41
Summary
This prediction is currently active. The prediction for Trinity Biotech ADR disappoints with a performance of -14.88%. This prediction currently runs until 23.10.24. The prediction end date can be changed by StockNews_com at any time. StockNews_com has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Trinity Biotech ADR | - | - |
iShares Core DAX® | 1.851% | 5.158% |
iShares Nasdaq 100 | 1.573% | 2.589% |
iShares Nikkei 225® | -0.412% | -2.857% |
iShares S&P 500 | 1.128% | 2.485% |
Comments by StockNews_com for this prediction
In the thread Trinity Biotech ADR diskutieren
Trinity Biotech plc (NASDAQ: TRIB) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
Ratings data for TRIB provided by MarketBeat